TCR2 Therapeutics (TCRR) PT Raised to $58 at Mizuho Securities
Tweet Send to a Friend
Mizuho Securities analyst Mara Goldstein raised the price target on TCR2 Therapeutics (NASDAQ: TCRR) to $58.00 (from $33.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
